Home / Business and Economy / OMRON Healthcare Boosts Investment in India's Tricog to Tackle Heart Disease Epidemic
OMRON Healthcare Boosts Investment in India's Tricog to Tackle Heart Disease Epidemic
12 Nov
Summary
- OMRON Healthcare makes second investment in Indian AI medtech startup Tricog
- Partnership aims to expand remote cardiac monitoring and early detection services in India
- Tricog's AI-powered platform has screened over 31 million patients, identifying 1 million critical cases

In a significant move to address India's pressing cardiovascular health challenges, OMRON Healthcare has announced additional investment in the India-based AI medtech startup Tricog Health. This latest investment, coming two years after OMRON's initial backing of Tricog in 2023, further strengthens the strategic partnership between the two companies.
India is facing a growing heart disease epidemic, with cardio- and cerebrovascular diseases being the top two causes of death in the country. Against the backdrop of changing lifestyles and a rapidly aging population, the patient numbers are only expected to rise. However, healthcare providers in India face constraints, including a severe shortage of qualified cardiologists to analyze critical data like electrocardiograms (ECGs).
To tackle these challenges, Tricog Health has developed a cutting-edge AI-based platform that integrates with the expertise of over 100 in-house clinical specialists. This powerful combination enables the timely provision of preventive care for those in need. Since 2023, OMRON Healthcare and Tricog have been collaborating on the development and launch of KeeboHealth, a remote monitoring service for heart-failure patients that combines Tricog's AI-based ECG analytics with OMRON's connected devices.
Advertisement
Through this new investment, OMRON Healthcare aims to further strengthen its strategic partnership with Tricog, setting ambitious joint goals to introduce solutions tailored to local clinical needs in India. The collaboration is also a crucial component of OMRON Healthcare's corporate mission, "Going for ZERO," which seeks to eliminate adverse cardiovascular events in the future.




